Senior management professional and entrepreneur with 30+ years of experience in drug development and epidemiology; Founding member/founder of two companies.Pharmaceutical industry experience spans across Clinical Development, Pharmacovigilance, Scientific Writing, RWE and HEOR; experience includes setting up and building expertise and operations in these areas.Currently responsible for clinical development and RWE practice in NTT DATA’s Life Sciences Consulting organization

Sanish is the R&D Director at Johnson & Johnson Innovative Medicine, India, and a former President & Executive Committee Member of the Indian Society for Clinical Research (ISCR), India's leading clinical research organization. A trained Clinical Pharmacologist (MD, DM) and Fellow of ACCP, USA, he brings about 18 years of experience in the pharmaceutical industry, spanning Clinical Development, Clinical Pharmacology, Medical Affairs, and New Product Strategy across India and Emerging Markets. He is passionate about advancing clinical research education, integrating ethics into clinical trials, and driving innovation in rare disease development.

Gaurav holds a PhD in Biotechnology (University of Pune) and an MBA (BITS Pilani). With 25+ years in academia and healthcare, he specializes in R&D, regulatory planning, and lifecycle management. Since 2021, he has led Parexel Bengaluru’s 350+ Global Regulatory Affairs team. Previously, he held senior roles at IQVIA, INC Research, Biocon, Clinigene, and Avesthagen. An ISCR Executive Committee member (2023-25), he chaired its South Chapter (2019-23) and Regulatory Council (2009-19). He received ISCR’s “President Award” (2019, 2020) and “Hall of Fame” Award (2018). He also chairs Narayana Health’s Academic Ethics Committee. A GCP expert, he has trained professionals for 12+ years and published 10 research papers.

Dr. Vivek Ahuja is a physician-turned pharmaceutical leader with 25 years of experience across pharmacovigilance, clinical research, public health, and technology. In 2005 he pioneered pharmacovigilance in India by establishing the first global PV unit at Ranbaxy. He is Executive Vice President at EVERSANA leading global pharmacovigilance, with prior leadership roles at Sun Pharma, ArisGlobal, Baxter, and PATH. He holds an MBBS (GMC Chandigarh), MD (AIIMS New Delhi) and MBA (MDI Gurgaon). He co-authored the Pharmacovigilance Programme of India (2010) and supported PV systems in Nepal, Bangladesh, and China. An international speaker, he advocates simplifying pharmacovigilance through practical innovation.

Dr. Subrat is a qualified medical physician with an M.D. in Pharmacology from Seth G.S. Medical College, Mumbai University. He brings over 23 years of experience in Medical Affairs, Clinical Research, and Pharmacovigilance. Currently Regional Director, Medical Affairs (Women’s Health) for Asia Pacific, Eastern Europe, Middle East, and Africa, he has led numerous cross-functional medical projects. A published author and speaker, his expertise spans Women’s Health, Oncology, Respiratory, Dermatology, Analgesics, and Anti-microbials. He is also a Fellow of the MSD Global Fellowship Project with JHPIEGO.

An influential and data-driven executive professional with a robust background in the Pharmaceutical and Public Health sectors, bringing a unique blend of expertise in leading digital transformation initiatives and leveraging data to guide corporations through complex business changes. Recognized as a thought leader/industry expert in the data, digital health, and AI ecosystem, excelling at understanding industry trends and developing strategic perspectives to guide digital health and AI partnerships and investments. High-level analytical skills and deep expertise in drug development, clinical, safety and regulatory processes, data management, digital innovation, and governance.

Dr. Praveen R has over 15 years of experience in medical affairs, specializing in diabetes, immunology, and oncology. Currently, he serves as the General Manager and Head of Global Medical Affairs at Biocon Biologics Ltd, where he develops and implements medical strategies and engages with thought leaders. He leads the medical plan focusing on insight generation, medical education, real-world evidence, and publications. He has held significant positions at Biocon Biologics Ltd, Abbott Healthcare, and GVK Bioscience, contributing to clinical development, strategic planning, and compliance with regulatory standards.

Ashok serves as General Manager & Executive Director, DIA India, leading strategy, operations, and partnerships across the country. A pharmaceutical physician with 29 years of experience spanning the Indian Army, academia, and leading global pharmaceutical companies, he brings deep expertise in clinical development, medical affairs, regulatory affairs, and drug safety. Prior to joining DIA, Ashok held senior leadership roles at Novartis, Dr. Reddy’s Laboratories, and Themis Medicare, leading complex development programs and cross-functional teams. He holds an MBBS and MD in Pharmacology, with executive education from IIM Calcutta and certification in Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine, UK.

A seasoned Pharmaceutical Physician with 20+ years of expertise in medical affairs, pharmacovigilance, AI applications, DTx, marketing approvals, licensing, compliance, IP, post-marketing obligations, and supply chain. Dr. Senthil holds an M.D. in Pharmacology from Seth GS Medical College & KEM Hospital and a Diploma in Business Management from Welingkar Institute. With numerous publications, he excels in identifying data gaps, generating and analyzing data, real-world evidence, and patient journey mapping, driving advancements across therapy areas.

Dr. Srirupa Das, a Pharmaceutical Physician with 24 years of experience, has held leadership roles including Country Medical Director, and APAC Lead for Global Scientific Affairs at Johnson and Johnson MedTech; Country Medical Director at Abbott India Ltd. Her expertise spans Clinical Development, Medical and Regulatory Affairs, Portfolio Strategy, and Governance. She has managed proprietary, specialty and established portfolios; domestic and global markets. She has driven brand leadership through innovative evidence strategies and contributed to healthcare policy shaping in India.Dr. Das holds an MD in Pharmacology, and a postgraduate diploma in marketing from NMIMS, Mumbai.

Shweta brings over 25 years of professional experience, with more than 20 years in the CRO and pharmaceutical industry. She has extensive expertise in project management and people leadership, gained through a long and successful career at IQVIA, where she has held multiple leadership roles and led large, diverse teams.Throughout her tenure, Shweta has been instrumental in developing and mentoring CRAs and people managers, enabling their progression into broader and more complex roles within the organization. Her leadership style focuses on capability building, operational excellence, and sustainable talent development.

Clinical Research Professional with 27+ years of experience across pharma, academia, and government. Began career as a CRA at AstraZeneca India, later holding leadership roles at MSD, Bharat Serums & Vaccines, and THSTI (Govt. of India). Currently serves as General Secretary of the Indian Society for Clinical Research (ISCR) and Adjunct Visiting Faculty at Manipal College of Pharmaceutical Sciences. Holds an M.Pharm in Pharmacology, an Executive MBA from IIM Lucknow, and a Doctorate in Business Administration from SSBM, Geneva.

Dr. Manjusha Rajarshi has over 30 years in the Pharma industry. She holds an M.Pharm, Ph.D., Diplomas in IPR, and a PG Diploma in Health Promotion from PHFI, New Delhi. Starting as a management trainee at B. Braun, she advanced through Unichem, Aventis Pasteur, Bayer, and Servier India, specializing in regulatory affairs, clinical research, patents, and trademarks. Currently, she is a freelance consultant and runs REGULUS HEALTHCARE in Mumbai. She is also a Partner at Roots-simplified Research and Consulting LLP, focusing on health research programs, scientific content, and strategic consulting, with several original research papers to her credit.

Dr. Sushant Kumar is the Head-R&D at ImmunoACT and contributed to India’s first and world’s most affordable CAR-T cell therapy, NexCAR19™. He leads the end-to-end development of CAR-T cell therapies including in vivo CAR-T therapies for cancers. He holds an MTech from IIT Guwahati, a PhD from IIT Bombay, and completed his postdoc training at the University of Pennsylvania, USA. He has authored more than 20 peer-reviewed publications in international journals, and has received several international recognitions, including the Young Investigator Award and international research grants, served on the Scientific Advisory Council of Uplifting Athletes, USA, and has been a guest editor and reviewer for several international journals.

Dr J Vijay is the Founder, MD & CEO of Oviya MedSafe, a global Pharmacovigilance consulting & Drug Safety services providing company based in India and the United Kingdom. He is the first Indian to have received the Fellowship of the Pharmaceutical Information & Pharmacovigilance Association (PIPA), UK. He has been the India Regional Editor of Global Forum, a DIA publication, since 2017. He served as Chair of the Pharmacovigilance Council of the Indian Society for Clinical Research (ISCR) since the Council’s inception in 2015 until 2019. He was the Chairman of the Indian Medical Association (IMA) Headquarters Standing Committee for Pharmacovigilance for 2021. He is a recipient of IMA’s Leadership Excellence Award.